From: ARMCX1 inhibits lung adenocarcinoma progression by recruiting FBXW7 for c-Myc degradation
Factors | Â | n | ARMCX1 expression | X2 | P value | |
---|---|---|---|---|---|---|
Low | High | |||||
Age(y) | < 50 | 10 | 7 | 3 | 0.014 | 0.905 |
≥ 50 | 78 | 56 | 22 | |||
Gender | Male | 52 | 37 | 15 | 0.011 | 0.913 |
Female | 36 | 26 | 10 | |||
Clinical stage* | I-II | 48 | 29 | 19 | 8.874 | 0.002 |
III-IV | 27 | 25 | 2 | |||
T stage* | T1-T2 | 65 | 43 | 22 | 4.292 | 0.038 |
T3-T4 | 20 | 18 | 2 | |||
N stage* | N0-N1 | 55 | 36 | 19 | 4.383 | 0.036 |
N2-N3 | 20 | 18 | 2 |